Middle East and North Africa
Applications are invited for collaborations for exploratory and developmental work on HIV/AIDS in the low- and middle-income countries of the Middle East and North Africa (MENA), as defined by the World Bank: Algeria, Djibouti, Egypt, Iran, Iraq, Jordan, Lebanon, Libya, Morocco, Oman, Syria, Tunisia, West Bank and Gaza, and Yemen. Specific areas of research include, but aren't limited to, epidemiologic studies, prevention research from both biomedical and social/behavioral perspectives, studies of social factors affecting the spread of HIV in the region, and research on women and youth. Collaborations must involve U.S. investigators from a partnering U.S. organization and one or more research teams in the MENA region. The collaborative effort should help foster the development of HIV-relevant research infrastructure and expertise in the region and have the potential to lead to further research and improvements in public health.
The U.S.-Egypt Joint Science and Technology Fund (Joint Fund) was established under the U.S.-Egypt Technology Cooperative Agreement first signed in 1995 and then renewed in 2001 by the United States and the Arab Republic of Egypt.
Every year, the Joint Fund sponsors two competitive grants programs that bring together U.S. and Egyptian Scientists. The Collaborative Research Grant program funds projects submitted by U.S. and Egyptian scientists who are interested in working together on a joint research project. The maximum grant amount is US $60,000, covering a period of 1-3 years, shared by both partners. The Junior Scientist Development Visit Grant provides opportunity for short-term (maximum six months) practical training of junior scientists. A junior scientist is defined as someone who has earned a Ph.D. within the last ten years or, for the U.S. scientists, the term may also include someone currently in a Ph.D. program or a completed master's degree. The maximum grant is $15,000.
Additional information and the current year's Program Announcement may be found at http://cairo.usembassy.gov/usegypt/index.htm.
For more information, contact Judy Levin (firstname.lastname@example.org), FIC Program Officer for the Middle East, North Africa and Sub-Saharan Africa.
The Middle East Cancer Consortium (MECC) was established through an official agreement of the Ministries of Health of Cyprus, Egypt, Israel, Jordan, and the Palestinian Authority. The agreement was signed in Geneva in May 1996.
The objective of the MECC is to reduce the incidence and impact of cancer in the Middle East through the solicitation and support of collaborative research. Since its inception, MECC's major activities have been the Cancer Registry Project (CRP) and the Small Grants Programme.
Additional information may be found at http://mecc.cancer.gov/.
The BSF is a grant-awarding institution that promotes research cooperation between scientists from the United States and Israel. It was established by the two governments in 1972 and began awarding grants in 1974. Its purpose is to promote and support cooperation between the United States and Israel in scientific and technological research for peaceful purposes.